Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,865 JPY
Change Today -30.00 / -1.58%
Volume 62.6K
4574 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

taiko pharmaceutical co ltd (4574) Snapshot

Open
¥1,895
Previous Close
¥1,895
Day High
¥1,895
Day Low
¥1,862
52 Week High
12/1/14 - ¥2,532
52 Week Low
05/14/14 - ¥1,325
Market Cap
25.3B
Average Volume 10 Days
81.4K
EPS TTM
¥129.13
Shares Outstanding
13.6M
EX-Date
03/27/15
P/E TM
14.4x
Dividend
¥15.00
Dividend Yield
1.34%
Current Stock Chart for TAIKO PHARMACEUTICAL CO LTD (4574)

Related News

No related news articles were found.

taiko pharmaceutical co ltd (4574) Related Businessweek News

No Related Businessweek News Found

taiko pharmaceutical co ltd (4574) Details

Taiko Pharmaceutical Co., Ltd. manufactures, procures, and sells non-prescription (OTC) drugs in Japan, Mainland China, Hong Kong, and Taiwan. It offers gastrointestinal drugs under the Seirogan, Seirogan TOI A, and Pishut brands for the treatment of loose stools, diarrhea, food poisoning, water poisoning, vomiting, and similar conditions; and designated quasi drugs comprising Trumpet Intestinal Regulator BF, as well as sells Hiya Kiogan, a prediatric drug. The company also manufactures and sells sanitation control products, such as Cleverin and WE'LL SHIELD; and sells LISPASS Cleverin generator, a machine which emits low concentrations of chlorine dioxide gas. In addition, it supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. Further, the company provides additives and pyroligneous acids for horticultural use. Taiko Pharmaceutical Co., Ltd. was founded in 1946 and is headquartered in Osaka, Japan.

200 Employees
Last Reported Date: 06/26/14
Founded in 1946

taiko pharmaceutical co ltd (4574) Top Compensated Officers

Chief Executive Officer, President and Repres...
Total Annual Compensation: ¥116.4M
Compensation as of Fiscal Year 2014.

taiko pharmaceutical co ltd (4574) Key Developments

Taiko Pharmaceutical Co., Ltd. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2015

Taiko Pharmaceutical Co., Ltd. provided year end dividend guidance for the fiscal year ending March 31, 2015. For the year, the company announced that it expects to pay year end dividend guidance of JPY 15.00 per share compared to JPY 25.00 per share paid a year ago.

Taiko Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2014; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015

Taiko Pharmaceutical Co., Ltd. reported consolidated earnings results for the nine months ended December 2014. For the quarter, the company reported net sales of JPY 7,207 million compared to JPY 7,845 million a year ago. Operating income was JPY 2,528 million compared to JPY 2,619 million a year ago. Ordinary income was JPY 2,743 million compared to JPY 2,717 million a year ago. Net income was JPY 1,804 million compared to JPY 1,918 million a year ago. Diluted net income per share was JPY 138.42 compared to JPY 145.17 a year ago. The company provided earnings guidance for the fiscal year ending March 31, 2015. For the year, the company expects net sales of JPY 8,900 million, operating income of JPY 2,200 million, ordinary income of JPY 2,350 million, net income of JPY 1,500 million and net income per share of JPY 117.74.

Taiko Pharmaceutical Co., Ltd. to Report Q3, 2015 Results on Feb 12, 2015

Taiko Pharmaceutical Co., Ltd. announced that they will report Q3, 2015 results on Feb 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4574:JP ¥1,865.00 JPY -30.00

4574 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4574.
View Industry Companies
 

Industry Analysis

4574

Industry Average

Valuation 4574 Industry Range
Price/Earnings 15.0x
Price/Sales 2.6x
Price/Book 1.9x
Price/Cash Flow 15.5x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIKO PHARMACEUTICAL CO LTD, please visit www.seirogan.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.